News: Valeant Pharmaceuticals Intl Inc (NYSE:VRX) belongs to Healthcare sector and Drug Delivery industry. Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (“Valeant”) today declared that the Board of Directors has chosen Richard (Dick) U. DeSchutter to serve as a chief, compelling January 2, 2017. With the expansion of Mr. DeSchutter, Valeant has expanded the extent of its Board to 13 individuals, 12 of whom are autonomous.
“We are pleased to welcome Dick to our top managerial staff,” said Joseph C. Dad, Chairman and CEO of Valeant. “His reputation of pharmaceutical organization authority joined with his operational and money related counseling background make him a perfect expansion to our board. We anticipate his vital experiences as we reposition and reinvigorate the organization in 2017.”
Preceding his retirement, Mr. DeSchutter served as the Chairman and Chief Executive Officer of DuPont Pharmaceuticals Company from July 2000 until its securing by Bristol-Myers Squibb in October 2001. Preceding DuPont, Mr. DeSchutter was a Director and Chief Administrative Officer of Pharmacia Corporation, which was made through the merger of Monsanto Company and Pharmacia and Upjohn in 2000. Before the merger, Mr. DeSchutter was a Director, Vice Chairman and Chief Administrative Officer for Monsanto. From 1995 to 1999, he served as Chairman and CEO of G.D. Searle and Co., Monsanto’s entirely claimed pharmaceutical backup.
Mr. DeSchutter right now serves as an executive of AuVen Therapeutics and Applied Silver, Inc. He was already Chairman of Incyte Corporation (2003 to 2015); Durata Therapeutics Inc. (2012 to 2014); and Lead Independent Director (2011 to 2014) and Director (2001 to 2014) of Smith and Nephew plc.
Mr. DeSchutter earned a Bachelor of Science degree (1963) and a Master of Science Degree (1965) in Chemical Engineering from the University of Arizona.
Summary: Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational forte pharmaceutical organization that creates, makes and markets an expansive scope of pharmaceutical items basically in the zones of dermatology, gastrointestinal issue, eye wellbeing, neurology and marked generics.